Brolucizumab
Switch Study
Approved small_molecule completed
Quick answer
Brolucizumab for Age-Related Macular Degeneration is a Approved program (small_molecule) at The University of Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The University of Hong Kong
- Indication
- Age-Related Macular Degeneration
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed